Speaking Engagement

View from the Board: What Do Private Company Investors and Outside Directors Want from Their CEOs?

Bio Investor Forum 2016

18 Oct 2016 03:00 p.m. - 03:55 p.m.

Westin St. Francis Hotel
335 Powell Street
San Francisco, CA 94102

More than half of biotech CEOs are first-time CEOs; as such, many have less experience with engagement of a Board and the growth challenges of private companies than most of their investors. Building these critical relationships and leveraging the cumulative experience of the Board can greatly increase a company's success and ability to navigate obstacles. This panel of experienced outside directors will discuss best practices for effective CEO-board relationships and give CEOs insight into the expectations from their Board.


  • Michael J. O'Donnell, Partner, Morrison & Foerster


  • David Donabedian, PhD, Partner, Longwood Ventures
  • Charlotte Hubbert, PhD, Program Investment Officer,  Venture Investing at The Bill & Melinda Gates Foundation
  • Nina Kjellson, General Partner, Canaan Partners
  • Camille Samuels, Partner, Venrock



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.